Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

ERADIVIR

Filed by CGCN GROUP, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
$20,000.00
Expenses
Not reported
Registrant
CGCN GROUP, LLC
Client
ERADIVIR
Filing UUID
a86879a8-ac07-4ddc-8f9b-f959b38efc27
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.

Literal federal measure citations: H.R. 10545

DIS · Disaster Planning/Emergencies

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.

Literal federal measure citations: H.R. 10545

HCR · Health Issues

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.

Literal federal measure citations: H.R. 10545

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.